… vedolizumab, ustekinumab or tofacitinib. One preliminary multi-center study evaluating patients
treated … Among 29 patients with concurrent hepatitis B or hepatitis C infection, no cases of …

… a retrospective, multicenter study to assess both the safety and the effectiveness of TNF-alpha
inhibitors and ustekinumab in patients with psoriasis and chronic viral hepatitis B or C [65]. …

… of 28 cases of psoriasis treated with ustekinumab that was … , retrospective study was
performed on 958 patients with … You can change your cookie settings at any time by following …

… . Safety and effectiveness of ustekinumab and antitumour necrosis factor therapy in
patients with psoriasis and chronic viral hepatitis B or C: a retrospective, multicentre study in a …

… -label, multicentre study analyzed 660 patients receiving infliximab 5/… Newer approved
biologics as ustekinumab and secuki… Risk of reactivation, in chronic carriers of hepatitis B during …

… Hepatitis B virus reactivation is a well-known event in … , a retrospective analysis of 2148
patients with chronic arthritis or … with ustekinumab for recalcitrant psoriasis and psoriatic arthritis […

… study group reported in a multicenter, retrospective study in … trial to evaluate the efficacy and
safety of ustekinumab in the … for the intervention in chronic hepatitis B patients who had high …

… A retrospective study of 101 HBsAg-positive patients in Turkey … patients from 9 studies
who received antitumor necrosis … Another study of 220 patients with skin psoriasis with and …

… On the one hand, the use of anti-Tumor Necrosis Factor … Hepatitis B is a type of viral
hepatitis caused by the Hepatitis … due to psoriasis severity, the impact on the patient’s quality of …

… Nevertheless, a multicentre study of 46 patients treated with … for ustekinumab also seem to
demonstrate good efficacy and … literature to evaluate the impact of TB, hepatitis B and C, HIV, …